This is the classic website, which will be retired eventually. Please visit the modernized ClinicalTrials.gov instead.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT06017297
Brief Title: Neoadjuvant Tremelimumab and Durvalumab With Gem/Cis in Intrahepatic Cholangiocarcinoma (ESR-22-21719)

First Submitted : August 24, 2023
First Submitted that Met QC Criteria : August 24, 2023
First Posted : August 30, 2023

Last Update Submitted that Met QC Criteria : February 8, 2024
Last Update Posted : February 9, 2024